Today's Top 20 StoriesRSS
Medtronic's fourth quarter preliminary report is outpacing estimates. By Laura Dyrda -
The first patient was treated with an anatomically-adapted three-dimensional printed titanium fusion implant. By Laura Dyrda -
The Food and Drug Administration granted 47 orthopedic- and spine-related devices in April.  By Laura Dyrda -

Incorporating opioid-reducing strategy

Join a panel of surgeons to hear the challenges and best practices of incorporating an opioid-reducing strategy in the management of postsurgical pain. Register here for the upcoming webcast on May 28. 
The Spine Journal published a study examining the non-medical factors for spine trauma patient transfer at Level III and Level IV trauma centers. By Laura Dyrda -
The American Fitness Index ranking released by the American College of Sports Medicine and the Anthem Foundation ranked the top 50 metropolitan areas in the United States for their fitness levels.  By Brandon Howard -
The bone morphogenetic protein market shows sluggish growth in some areas, according to a Research and Markets report. By Laura Dyrda -
InVivo Therapeutics named a new site for the ongoing Neuro-Spinal Scaffold for patients with acute spinal cord injury. By Laura Dyrda -

Improving patient acquisition through marketing

There is a huge paradigm shift going on that has moved the power of information from the practice to the patient.  77% of individuals are searching for a reputable doctor online and 1/3 of consumers trust the internet as a reliable source for healthcare information.
Implanet received FDA clearance to market its 3.5 mm, 4 mm, 4.5 mm and 6 mm JAZZ rods in the United States. By Laura Dyrda -
LDR COO James Burrows sold several shares of the company last Friday, according to a Mideast Times report. By Laura Dyrda -
Medtronic is pledging several thousand dollars to support earthquake relief efforts in Nepal. By Laura Dyrda -
A new study published in Spine examines the best practices for measuring patient outcomes for spinal stenosis. By Laura Dyrda -
Biologic Therapies received U.S. Food and Drug Administration clearance for the Bio-MAC and Bio-CORE Bone Marrow Cannulas.  By Laura Dyrda -
Here are 14 key notes on spine and orthopedic device companies this week.  By Anuja Vaidya -
Minimally invasive surgery is sweeping the spine field. It allows surgeons to perform less morbid procedures with less pain and faster recovery for the patients. Infection rates are also lower with less invasive procedures. Surgeons are using a variety of methods to access the spine in the least disruptive way possible. By Laura Dyrda -
A new study published in the Journal of Spinal Disorder & Techniques examined the effectiveness of MRI in identifying issues for spinal trauma patients. By Laura Dyrda -
Brussels-based Bone Therapeutics reported first quarter results. By Laura Dyrda -
Stryker has a new group of analysts covering their stock, according to a Sleek Monkey report.  By Laura Dyrda -
American spine surgeon Chet Sutterlin, MD, responded to calls made by the non-profit Spinal Health International to help victims of the recent earthquakes in Nepal, according to an NBC News report. By Laura Dyrda -
A new group of analysts initiated coverage of K2M shares, according to a WKRB News & Analysis report. By Laura Dyrda -
Page 2 of 280